[{"id":6452,"regimens":[{"id":12581,"duration":{"id":6575,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5901,"name":"Amoxicillin","url":"cure-api2.ncats.io/v1/drugs/5901","rxNorm_id":null,"notes":null},"use_drug":[{"id":10436,"answer":"Other","answer_other":"Likely given for bacterial cover","regimen":12581}],"created":"2020-11-13T18:31:59.608650Z","updated":"2020-11-13T22:07:28.533612Z","dose":null,"frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":6452},{"id":12582,"duration":{"id":6576,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6772,"name":"Chloroquine","url":"cure-api2.ncats.io/v1/drugs/6772","rxNorm_id":null,"notes":null},"use_drug":[{"id":10373,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12582},{"id":10374,"answer":"In a novel combination with another drug","answer_other":"","regimen":12582}],"created":"2020-11-13T18:31:59.616416Z","updated":"2020-11-13T22:07:28.493232Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6452},{"id":12616,"duration":null,"drug":{"id":9229,"name":"Nadroparin","url":"cure-api2.ncats.io/v1/drugs/9229","rxNorm_id":null,"notes":null},"use_drug":[{"id":10437,"answer":"Other","answer_other":"For thrombosis prophylaxis","regimen":12616}],"created":"2020-11-13T22:07:28.516722Z","updated":"2020-11-13T22:07:28.534481Z","dose":"3800 IU, later increased to 5700 IU","frequency":"daily","route":"SC","severity":null,"severity_detail":null,"comments":null,"report":6452},{"id":12617,"duration":null,"drug":{"id":11408,"name":"Tissue plasminogen activator","url":"cure-api2.ncats.io/v1/drugs/11408","rxNorm_id":19,"notes":""},"use_drug":[{"id":10438,"answer":"It was not used in a new way","answer_other":"","regimen":12617},{"id":10439,"answer":"Other","answer_other":"For cerebral infarct","regimen":12617}],"created":"2020-11-13T22:07:28.520764Z","updated":"2020-11-13T22:07:28.535344Z","dose":null,"frequency":"","route":"","severity":null,"severity_detail":null,"comments":null,"report":6452},{"id":12618,"duration":null,"drug":{"id":6964,"name":"Clopidogrel","url":"cure-api2.ncats.io/v1/drugs/6964","rxNorm_id":null,"notes":null},"use_drug":[{"id":10440,"answer":"It was not used in a new way","answer_other":"","regimen":12618},{"id":10441,"answer":"Other","answer_other":"for secondary stroke prevention","regimen":12618}],"created":"2020-11-13T22:07:28.525145Z","updated":"2020-11-13T22:07:28.536171Z","dose":null,"frequency":"","route":"","severity":null,"severity_detail":null,"comments":null,"report":6452},{"id":12619,"duration":null,"drug":{"id":10749,"name":"Tinzaparin","url":"cure-api2.ncats.io/v1/drugs/10749","rxNorm_id":null,"notes":null},"use_drug":[{"id":10442,"answer":"It was not used in a new way","answer_other":"","regimen":12619},{"id":10443,"answer":"Other","answer_other":"Initiated after PE was diagnosed","regimen":12619}],"created":"2020-11-13T22:07:28.529363Z","updated":"2020-11-13T22:07:28.537078Z","dose":"18,000 IU","frequency":"daily","route":"sc","severity":null,"severity_detail":null,"comments":null,"report":6452}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8480,"answer":"Clinical assessment","answer_other":"","report":6452},{"id":8481,"answer":"Imaging","answer_other":"","report":6452}],"how_diagnosis":[{"id":14493,"answer":"Clinical assessment","answer_other":"","report":6452},{"id":14494,"answer":"PCR","answer_other":"","report":6452},{"id":14520,"answer":"Imaging","answer_other":"","report":6452}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4584,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6452}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[],"created":"2020-11-13T18:29:40.000455Z","updated":"2020-11-13T22:07:28.479001Z","title":"Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32386986,"doi":"10.1016/j.thromres.2020.04.046","article_url":"https://pubmed.ncbi.nlm.nih.gov/32386986/","pub_year":2020,"published_authors":"Brüggemann R\r\nGietema H\r\nJallah B\r\nTen Cate H\r\nStehouwer C\r\nSpaetgens B","article_author_email":"Author email could not be found.","journal":"Thrombosis research","abstract":"Hypercoagulability is a major contributor to COVID-19 related pulmonary complications\r\nCommonly used approaches may be insufficient to ameliorate the risk of thromboembolic events in patients with COVID-19\r\nEven when on thromboprophylaxis, it is crucial to remain vigilant for the occurrence of VTE in patients with COVID-19.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"51-60 years","sex":"Male","ethnicity":null,"country_contracted":"Netherlands","country_treated":"Netherlands","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":true,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"peripheral arterial disease","pregnant":false,"unknown":false,"site_of_disease":"lungs","clinical_syndrome":"pneumonia, respiratory tract infection, pulmonary embolism","severity":"ICU/Critical Care","prev_treatment":"","unusual":"Arterial and venous thromboembolic disease in a patient with COVID-19","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"While the patient was still on treatment","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"This patient has a history of peripheral arterial disease. This patient received oxygen via nasal cannula, and prophylactic low molecular weigh heparin. They also received IV rt-PA and after 24 h clopidogrel initiated for secondary stroke prevention. CT pulmonary angiography revealed pulmonary embolism in the right pulmonary artery and bilateral (sub)segmental pulmonary embolism were found. CT-imaging of the brain (including CT-angiography and CT-perfusion) showed no brain haemorrhage or arterial occlusion, yet a defect right frontal with large mismatch between perfusion and vascular volume recordings, indicative of right frontal lobe infarction, was seen.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5901,6772,6964,9229,10749,11408]}]